Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOS2 | P35228 | 2/20 | 0.33 |
| ▸ | NOS3 | P29474 | 1/20 | 0.33 |
| ▸ | NOS1 | P29475 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | BLM | P54132 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27725254 | 0.88 | CYP2D6 (0.35) | MEN1KMT2A | |
| SCHEMBL11942459 | 0.78 | — | — | |
| SCHEMBL13686684 | 0.78 | — | — | |
| SCHEMBL8245418 | 0.78 | — | — | |
| SCHEMBL6280246 | 0.77 | — | — | |
| SCHEMBL1298622 | 0.77 | — | — | |
| SCHEMBL17904505 | 0.77 | — | — | |
| SCHEMBL16453949 | 0.77 | — | — | |
| SCHEMBL31472606 | 0.77 | — | — | |
| SCHEMBL27731852 | 0.73 | KMT2A (0.40) | NOS2NOS3NOS1MEN1BLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104379744-A | Single-stranded nucleic acid molecule for controlling gene expression having delivery function | BONAC CORP | 2015-02-25 | — | — | CN | disclosed |
| CN-102070451-A | Methods and compounds producing dipeptidyl peptidase IV inhibitors and intermediates thereof | BRISTOL MYERS SQUIBB CO | 2011-05-25 | — | — | CN | disclosed |
| CN-101108809-B | 1- (alkylaminoalkyl-pyrrolidine-/piperidinyl) -2, 2-diphenylacetamide derivatives as muscarinic receptor antagonists | THERAVANCE INC | 2010-07-14 | — | — | CN | disclosed |
| CN-101108809-A | 1- (alkylaminoalkyl-pyrrolidine-/piperidinyl) -2, 2-diphenylacetamide derivatives as muscarinic receptor antagonists | THERAVANCE INC (US) | 2008-01-23 | — | — | CN | disclosed |
| CN-1805927-A | 1- (alkylaminoalkyl-pyrrolidine-/piperidinyl) -2, 2-diphenylacetamide derivatives as muscarinic receptor antagonists | THERAVANCE INC (US) | 2006-07-19 | — | — | CN | disclosed |